Other Income & Expense
Non-Marketable Equity Securities Impairment
Year-over-year, this metric declined by 100.0%, from $579.00M to $0.00. This increase may warrant attention — for this metric, lower values are generally preferred.
Analysis
StatementIncome Statement
SectionOther Income & Expense
CategoryRisk
SignalLower is better
VolatilityVolatile
First reportedQ1 2022
Last reportedQ4 2025Feb 6, 2026
How to read this metric
Higher impairment charges suggest declining valuations in the private equity or startup ecosystem.
Detailed definition
This represents impairment losses recognized on equity investments that do not have readily determinable fair values. It...
Peer comparison
Standard for companies with large corporate venture capital arms.
Metric ID:
c_non_marketable_equity_securities_impairmentHistorical Data
4 years
| FY'22 | FY'23 | FY'24 | FY'25 | |
|---|---|---|---|---|
| Value | $0.00 | $0.00 | $2.32B | $0.00 |
| YoY Change | — | — | — | -100.0% |
Range$0.00 – $2.32B
Avg YoY Growth-100.0%
Median YoY Growth-100.0%
Non-Marketable Equity Securities Impairment at Other Companies
Frequently Asked Questions
- What is Philip Morris International's non-marketable equity securities impairment?
- Philip Morris International (PM) reported non-marketable equity securities impairment of $0.00 in Q4 2025.
- How has Philip Morris International's non-marketable equity securities impairment changed year-over-year?
- Philip Morris International's non-marketable equity securities impairment decreased by 100.0% year-over-year, from $579.00M to $0.00.
- What does non-marketable equity securities impairment mean?
- A reduction in the recorded value of private company investments due to poor performance.